Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma, Nature, vol.436, issue.7047, pp.117-122, 2005. ,
Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors, Am J Surg Pathol, vol.25, issue.1, pp.51-57, 2001. ,
Fifteen-year quest for microphthalmia-associated transcription factor target genes, Pigment Cell Melanoma Res, vol.23, issue.1, pp.27-40, 2010. ,
Microphthalmia-associated transcription factor gene amplification in metastatic melanoma is a prognostic marker for patient survival, but not a predictive marker for chemosensitivity and chemotherapy response, Clin Cancer Res, vol.13, issue.21, pp.6344-6350, 2007. ,
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma, Cancer Discov, vol.4, issue.1, pp.94-109, 2014. ,
Low MITF/ AXL ratio predicts early resistance to multiple targeted drugs in melanoma, Nat Commun, vol.5, p.5712, 2014. ,
Up-regulation of MET expression by alpha-melanocytestimulating hormone and MITF allows hepatocyte growth factor to protect melanocytes and melanoma cells from apoptosis, J Biol Chem, vol.282, issue.19, pp.14140-14147, 2007. ,
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature, Pigment Cell Res, vol.19, issue.4, pp.290-302, 2006. ,
GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells, Pigment Cell Melanoma Res, vol.24, issue.5, pp.932-943, 2011. ,
Mitf regulation of Dia1 controls melanoma proliferation and invasiveness, Genes Dev, vol.20, issue.24, pp.3426-3439, 2006. ,
MITF and PAX3 play distinct roles in melanoma cell migration; outline of a "genetic switch" theory involving MITF and PAX3 in proliferative and invasive phenotypes of melanoma, Front Oncol, vol.3, p.229, 2013. ,
Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome, 2011. ,
, Genes Dev, vol.25, issue.12, pp.1245-1261
Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma, Oncogene, vol.30, issue.20, pp.2319-2332, 2011. ,
Improved survival with ipilimumab in patients with metastatic melanoma, N Engl J Med, vol.363, issue.8, pp.711-723, 2010. ,
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients, Nature, vol.515, issue.7528, pp.563-567, 2014. ,
Migrating into the tumor: a roadmap for T cells, Trends Cancer, vol.3, issue.11, pp.797-808, 2017. ,
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment, Nat Commun, vol.6, p.8755, 2015. ,
Pax3 downregulation and shut-off of melanogenesis in melanoma B16/F10.9 by interleukin-6 receptor signaling, J Biol Chem, vol.277, issue.17, pp.15132-15141, 2002. ,
Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression, Cancer Res, vol.68, issue.14, pp.5743-5752, 2008. ,
The macrophage migration inhibitory factor (MIF)-homologue D-dopachrome tautomerase is a therapeutic target in a murine melanoma model, Oncotarget, vol.5, issue.1, pp.103-107, 2014. ,
The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations, Pigment Cell Melanoma Res, vol.29, issue.5, pp.590-597, 2016. ,
The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosis, Genes Dev, vol.19, issue.17, pp.1980-1985, 2005. ,
FANCD2 functions as a critical factor downstream of MiTF to maintain the proliferation and survival of melanoma cells, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02424498
Selective bispecific T cell recruiting antibody and antitumor activity of adoptive T cell transfer, J Natl Cancer Inst, vol.107, issue.1, p.364, 2015. ,
In vitro comparison between mouse B16 and human melanoma cell lines of the expression of ICAM-1 induced by cytokines and/or hyperthermia, J Dermatol, vol.24, issue.6, pp.351-360, 1997. ,
Loss of PTEN promotes resistance to T cell--mediated immunotherapy, Cancer Discov, vol.6, issue.2, pp.202-216, 2016. ,
Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF, PLoS One, vol.3, issue.7, p.2734, 2008. ,
Evaluation of tumor-infiltrating leukocyte subsets in a subcutaneous tumor model, J Vis Exp, vol.98, 2015. ,
The pancreatic cancer microenvironment: an immunologic battleground, Oncoimmunology, vol.3, issue.8, p.950171, 2014. ,
Of mice and not men: differences between mouse and human immunology, J Immunol, vol.172, issue.5, pp.2731-2738, 2004. ,
Development of a novel chemokine-mediated in vivo T cell recruitment assay, J Immunol Methods, vol.331, issue.1-2, pp.127-139, 2008. ,
Chemoattractant receptors BLT1 and CXCR3 regulate antitumor immunity by facilitating CD8+ T cell migration into tumors, vol.197, pp.2016-2026, 2016. ,
Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming, Nat Immunol, vol.5, issue.12, pp.1260-1265, 2004. ,
The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice, Br J Cancer, vol.79, issue.7-8, pp.1025-1031, 1999. ,
The role of chemokines in melanoma tumor growth and metastasis, J Invest Dermatol, vol.118, issue.6, pp.915-922, 2002. ,
Role of CXCL1 in tumorigenesis of melanoma, J Leukoc Biol, vol.72, issue.1, pp.9-18, 2002. ,
Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression, J Leukoc Biol, vol.62, issue.5, pp.588-597, 1997. ,
Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth, Cell Death Differ, vol.18, issue.1, pp.109-121, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00551041
MITF suppression improves the sensitivity of melanoma cells to a BRAF inhibitor, Cancer Lett, vol.409, pp.116-124, 2017. ,
Immune correlates of clinical outcome in melanoma, Immunology, vol.153, issue.4, pp.415-422, 2018. ,